Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01561170
Other study ID # N-20110052
Secondary ID
Status Active, not recruiting
Phase Phase 0
First received March 19, 2012
Last updated April 9, 2015
Start date October 2011
Est. completion date June 2015

Study information

Verified date April 2015
Source Northern Orthopaedic Division, Denmark
Contact n/a
Is FDA regulated No
Health authority Denmark: The Danish National Committee on Biomedical Research EthicsDenmark: Danish Dataprotection Agency
Study type Observational

Clinical Trial Summary

Chronically venous ulcer in lower extremities is a permanent and disabling disease. Venous insufficience is the main cause of chronic ulcer. There is a high prevalence and frequency of the disease, primarily among elderly people. Recently, electromagnetic field therapy has been tested on various diseases in musculoskeletal system with a beneficial effect. In recent years, there has been an increasing interest in using electromagnetic field therapy to treat chronically venous ulcer.

The hypothesis of the investigators is that the electronic magnetic field therapy improves the healing process and reduces pain for patients suffering from chronically venous ulcer. The investigators assume that the bioactivity is affected by a cellular response which affects the DNA synthesis, transcription og protein synthesis.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 36
Est. completion date June 2015
Est. primary completion date June 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- Patients who suffer from ulcer in lower extremities

- Patients who suffer from venous insufficience detected by duplex scanning or by a pressure on digits > 40 mmHg

- Patients with a regular need of compression stockings

- Age > 18 years

Exclusion Criteria:

- Age < 18 years

- Unability to read or understand Danish

- Patients who suffer from manifest neoplastic disorder

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective


Related Conditions & MeSH terms


Intervention

Device:
Active Pulsed Electro-Magnetic Field (PEMF)
One group of patients receive active devices. Both patients and investigator are blinded.
Placebo Pulsed Electro-Magnetic Field (PEMF)
One group of patients receive placebo devices. Both patients and investigator are blinded.

Locations

Country Name City State
Denmark Northern Orthopaedic Division, Aalborg University Hospital, Aalborg

Sponsors (1)

Lead Sponsor Collaborator
Northern Orthopaedic Division, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Reduction of ulcerous area. Measurement of ulcerous area in order to assessing the effect of the healing process. 3 months No
Secondary Pain reduction in proportion to Visual Analogue Scale (VAS). The pain reduction will be measured by VAS and an analysis of the medication between the two group of patients will be carried out in order to measure quality of life, adverse effects, ulceration, granulation tissue etc. 3 months No
See also
  Status Clinical Trial Phase
Completed NCT01990170 - Longterm Outcomes of Venous Ulcers After Foam Sclerotherapy N/A
Completed NCT03526913 - Role of Platelet Rich Plasma in Enhancing Graft Take in Chronic Venous Ulcers N/A